Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : VALENCE TECHNOLOGY (VLNC) -- Ignore unavailable to you. Want to Upgrade?

To: Pronichev who wrote (5280)	11/18/1998 11:15:00 AM
From: P. Ramamoorthy	Read Replies (1) \| Respond to of 27311

Patents - Abstracts alone do not help. The individual specs (claims) have to be compared for a better understanding of a patent's merits relative to competitors' position. When a technology field is "crowded" with patents, patents do not stop anyone from doing business. It is a question of getting a license to practice the art (that could be infringing), paying an appropriate royalty for the right to practice, etc. Royalty expenses are normally included in the profit analysis. Certain patents or a strong portfolio can be used as a negotiating tool. For a technology company, patents and royalty issues are routinely handled as part of doing business. As an investor, I am more interested in technology's commercial success, market size, margins, and earnings growth. Ram